Issue #18 — The Third Brain: What the JAMA Biotype Study Means for the ADHD Founder Who's Never Fit
🎯 TL;DR
An April 30, 2026 JAMA Psychiatry study scanned 1,154 brains and found ADHD isn't one disorder — it's at least three neurobiologically distinct conditions. The "extreme" third biotype has 45 abnormal brain regions vs. 26 for the other two, with emotional dysregulation as its signature. If you're the founder who's tried every protocol and still combusts, this might finally be why.
This week: Why the extreme ADHD biotype is the one that crashes hardest at scale — and what to do about it.
Read time: 6 minutes
🧠 Why your protocol stack keeps failing you
You've done the work. Stimulants. Strattera. Cold plunge. Whoop strap. Five different planners. A coach who specializes in "ADHD entrepreneurs." You read Hallowell. You read Barkley. You've watched every Russell Barkley YouTube lecture at 1.5x. And still — six months into the company, you blew up a co-founder relationship over a Slack message. Eight months in, you ghosted three investors for two weeks because one of them said "I'd want to see more traction." Twelve months in, you're sitting in your car at 2pm wondering if you're just bad at this.
You don't fit the ADHD founder script. The script says: distractible, novelty-seeking, hyperfocus when interested. You have all that — but the script doesn't explain the 4am rage spiral, or why one ambivalent email knocks you offline for a day. So you assumed you were doing ADHD wrong. New research suggests you've just had a different brain than the one those books were written about.
🔬 The three-biotype study that should rewrite your playbook
On April 30, 2026, JAMA Psychiatry published "Mapping ADHD Heterogeneity and Biotypes by Topological Deviations in Morphometric Similarity Networks" — Pan et al., a team using morphometric similarity network (MSN) analysis across 1,154 brain scans. They didn't ask "who has ADHD?" They asked "what shapes does ADHD actually take inside skulls?"
The answer: three. Three statistically distinct biotypes — not severities, not flavors, biotypes. Biotype 1 and Biotype 2 each show roughly 26 brain regions with significant structural deviation from neurotypical controls. Biotype 3 — the "extreme" subtype — shows 45. That's not 73% more ADHD. It's a different topology of cortical organization, concentrated in regions tied to emotional regulation: orbitofrontal cortex, amygdala connectivity, anterior cingulate.
| Biotype | Abnormal Regions | Signature | Founder Profile |
|---|---|---|---|
| 1 | ~26 | Attention/executive | Classic distractible — misses meetings, kills it on launch day |
| 2 | ~26 | Cognitive control | Slow start, perfectionism, decision paralysis |
| 3 | ~45 | Emotional dysregulation | High velocity, RSD spirals, scorched-earth conflict, burnout cliffs |
The Washington Post coverage flagged the sentence that should stop every founder cold:
"Psychiatry may have been treating fundamentally different brain disorders as if they were the same condition."
For decades, the canonical ADHD playbook — stimulants, behavioral activation, executive function coaching — was calibrated on populations dominated by Biotypes 1 and 2. If you're a Biotype 3 founder, you've been getting Subtype 1 prescriptions for a Subtype 3 brain. The Boston Globe's writeup quoted clinicians already asking whether emotional dysregulation should be a primary diagnostic axis rather than a footnote.
🛠 How to operate if you suspect you're Biotype 3
You won't get a biotype on your chart in 2026. The classification doesn't exist clinically yet. But you can operate as if it does. Here's the protocol shift:
- Treat emotional regulation as the load-bearing wall — not focus. If your meds give you focus but you still blow up relationships, your stack is incomplete. Ask your psychiatrist about adjuncts that target affective regulation: guanfacine, low-dose lamotrigine, or in some cases an SSRI alongside stimulants. (Get an actual prescriber. I'm a sheep with a newsletter.)
- Build a 24-hour rule into every high-stakes message. Anything you write in a dysregulated state goes into a drafts folder with a timer. Not "send later" — read later. The you who writes at 11pm should never have send privileges over the you who reads at 8am.
- Hire for emotional steadiness, not just execution. Your COO, EA, or co-founder needs to be the thermostat, not another thermometer. In a Biotype 3 system, two reactive operators is a fire.
- Pre-commit to recovery windows after conflict. A hard board meeting or tough customer call is not a "push through" event. Block 90 minutes after. Walk. No Slack. The crash is biological, not weakness.
The shift is from productivity stack to regulation stack. Productivity hacks are for Biotypes 1 and 2. You need infrastructure that catches you on the down-slope, because your down-slopes are steeper and the bottom is further from the surface.
⚡ The ADHD Angle
Rejection-sensitive dysphoria has been the diagnostic stepchild of ADHD for years — clinicians like William Dodson have argued for a decade that RSD is core, not comorbid. The Pan et al. paper is the first large-scale neuroimaging evidence that he was probably right for a specific population. If you're Biotype 3, RSD isn't a personality quirk you should fix with positive self-talk. It's a structural feature of your cortex. That reframing matters because shame doesn't survive contact with neuroanatomy.
For founders, this is enormous. The startup environment is a continuous RSD trigger generator: investor passes, customer churn, co-founder friction, public failure. A Biotype 1 brain gets bruised. A Biotype 3 brain gets dysregulated for 72 hours and ships an angry email that costs $400K and three relationships. Knowing this doesn't make you fragile — it makes you informed. You build the company around the brain you have, not the brain a 1998 textbook described.
🎯 This Week's Challenge
- Audit your last three blow-ups. Conflict, ghosting, scorched email — whatever. Was the trigger informational or emotional? If three out of three were emotional, you're getting signal about your biotype.
- Install the drafts-folder rule. Any message written after 9pm to a co-founder, investor, employee, or partner sits until morning. No exceptions this week.
- Book a consult that takes emotional dysregulation seriously. Search for a prescriber familiar with the Dodson framework or the Pan et al. paper. Bring the citation. Don't accept "everyone with ADHD feels like that."
See you Tuesday, L-P
P.S. — If this issue named something you've been carrying for years without language for, forward it to the one founder friend you trust enough to send the hard stuff to. The biotype frame is too useful to leave inside one inbox.
Divergent — Strategy for brains that don't do boring.